Form 4 holding
SVP, Regulatory Affairs
Lyra Therapeutics, Inc.
- Security class
- Stock Option
- Shares / value
- 30,000
- Estimated value
- Report date
- 12 Feb 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount